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Abstract
Protein Na-terminal acetylation (Nt-acetylation) is considered one of the most common protein modification in eukaryotes,
and 80-90% of all soluble human proteins are modified in this way, with functional implications ranging from altered protein
function and stability to translocation potency amongst others. Nt-acetylation is catalyzed by N-terminal acetyltransferases
(NATs), and in yeast five NAT types are identified and denoted NatA-NatE. Higher eukaryotes additionally express NatF.
Except for NatD, human orthologues for all yeast NATs are identified. yNatD is defined as the catalytic unit Naa40p (Nat4)
which co-translationally Nt-acetylates histones H2A and H4. In this study we identified and characterized hNaa40p/hNatD,
the human orthologue of the yeast Naa40p. An in vitro proteome-derived peptide library Nt-acetylation assay indicated that
recombinant hNaa40p acetylates N-termini starting with the consensus sequence Ser-Gly-Gly-Gly-Lys-, strongly resembling
the N-termini of the human histones H2A and H4. This was confirmed as recombinant hNaa40p Nt-acetylated the
oligopeptides derived from the N-termini of both histones. In contrast, a synthetically Nt-acetylated H4 N-terminal peptide
with all lysines being non-acetylated, was not significantly acetylated by hNaa40p, indicating that hNaa40p catalyzed H4 Na-
acetylation and not H4 lysine Ne-acetylation. Also, immunoprecipitated hNaa40p specifically Nt-acetylated H4 in vitro.
Heterologous expression of hNaa40p in a yeast naa40-D strain restored Nt-acetylation of yeast histone H4, but not H2A in
vivo, probably reflecting the fact that the N-terminal sequences of human H2A and H4 are highly similar to each other and
to yeast H4 while the N-terminal sequence of yeast H2A differs. Thus, Naa40p seems to have co-evolved with the human
H2A sequence. Finally, a partial co-sedimentation with ribosomes indicates that hNaa40p co-translationally acetylates H2A
and H4. Combined, our results strongly suggest that human Naa40p/NatD is conserved from yeast. Thus, the NATs of all
classes of N-terminally acetylated proteins in humans now appear to be accounted for.
Citation: Hole K, Van Damme P, Dalva M, Aksnes H, Glomnes N, et al. (2011) The Human N-Alpha-Acetyltransferase 40 (hNaa40p/hNatD) Is Conserved from Yeast
and N-Terminally Acetylates Histones H2A and H4. PLoS ONE 6(9): e24713. doi:10.1371/journal.pone.0024713
Editor: Axel Imhof, Ludwig-Maximilians-Universita¨t Mu¨nchen, Germany
Received June 30, 2011; Accepted August 16, 2011; Published September 15, 2011
Copyright:  2011 Hole et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by The Norwegian Research Council (project number 197136 to TA), The Norwegian Cancer Society (to JEV, JL and TA), the
Fund for Scientific Research – Flanders (Belgium) (project numbers G.0042.07 and G.0440.10), the Concerted Research Actions (project BOF07/GOA/012) from the
Ghent University and the Inter University Attraction Poles (IUAP06). PVD is a Postdoctoral Fellow of the Research Foundation - Flanders (FWO-Vlaanderen). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Thomas.Arnesen@mbi.uib.no
. These authors contributed equally to this work.
Introduction
Na-terminal acetylation (Nt-acetylation) occurs on 80–90% of
soluble human proteins and 50–70% of soluble yeast proteins [1–
3], making it one of the most widespread protein modifications in
eukaryotes. This modification was previously largely believed to
provide stability to proteins by preventing their degradation [4],
which is contrary to the recent finding of Hwang et al. indicating
that Nt-acetylation of specific N-termini in yeast acts as a
degradation signal for the Doa10 ubiquitin ligase, thereby
potentially targeting Nt-acetylated proteins for ubiquitin mediated
degradation [5]. Studies over the last years have also linked Nt-
acetylation to several other important protein functions, such as
sub-cellular protein targeting [6–10]. Nt-acetylation of specific
proteins is also essential for their correct activity or for their
interaction with other proteins [11–13]. More recently, an inverse
correlation between Nt-acetylation and the ability of a protein to
post-translationally enter the secretory pathway was revealed [14].
Taken together, these studies implicate Nt-acetylation as an
essential modulator of diverse protein properties [15]. Finally, a
defective NAT was recently found to be the cause of a lethal
syndrome affecting male infants, indicating that proper Nt-
acetylation is functionally essential in humans [16].
Nt-acetylation is catalyzed by N-terminal acetyltransferases
(NATs) and involves the transfer of the acetyl group from acetyl-
coenzyme A to the primary a-amino group of the very N-terminal
amino acid residue of a protein. The amino acid sequence at the
N-terminus is the major factor determining whether or not a given
protein is Nt-acetylated and by which NAT. In yeast, five different
NAT types are identified, designated NatA-NatE [17–21]. All
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NATs are composed of a catalytical subunit responsible for
catalyzing the acetylation reaction, and up to two auxiliary
subunits. The NATs are associated with ribosomes where the
acetylation reaction occurs cotranslationally as the peptide
extrudes from the ribosome, typically after 20-50 residues have
left the exit tunnel [22–24]. All NATs display by and large their
own unique substrate specificity; NatA acetylates Alanine, Serine,
Threonine, Glycine and Valine N-termini after initiator methio-
nine (iMet) removal by methionine aminopeptidases [17,18]. NatB
acetylates proteins with Met-Asn-, Met-Asp- and Met-Glu- N-
termini [25], while NatC acetylates the iMet when it is followed by
a hydrophobic residue [26]. For NatE no substrates have been
identified in yeast, and the yNatE deletion strain shows no obvious
phenotype [23]. However, studies on homologues from higher
eukaryotes show that this acetyltransferase has the potency to Nt-
acetylate Met-Leu- and similarly starting peptide N-termini in vitro
and is important for proper sister chromatid cohesion in vivo [27–
31]. However, no in vivo substrates explaining this phenotype are
identified. In addition to NatE, NatA, NatB, and NatC are also
characterized in higher eukaryotes and shown to be evolutionarily
conserved from yeast with respect to both complex composition
and substrate specificity [1,10,32,33]. Recently, an additional
NAT exclusively present in higher eukaryotes was identified and
designated Naa60/NatF. The acetyltransferase activity of hNatF
partially explains the increased levels of Nt-acetylation seen in
humans as compared to yeast [3].
The activity of Naa40p/NatD (Nat4) is so far characterized in
yeast only. yNaa40p was identified in the search for the
acetyltransferase responsible for Nt-acetylation of histone H4. In
the same study, histone H2A was also identified as a substrate for
yNaa40p [20]. Later, the activity of yNaa40p was denoted yNatD,
and the enzyme was predicted to act co-translationally since a
fraction of yNaa40p associated with ribosomes [34]. The N-
terminal residue of histone H4 is a serine, hence a predicted NatA
substrate. In contrast however to other NatA-type N-termini, Nt-
acetylation of H4 was not affected in strains with mutant NatA
subunits (ard1- or nat1-) suggesting that H4 is acetylated by another
NAT [17]. The basic histone tail makes these proteins unusual
substrates for a NAT since such residues are predicted to be
inhibitory for acetylation [35]. In addition to perhaps acetylating
only two selected substrates, H2A and H4, yNaa40p is also
unusual in its requirement for as many as 20-50 available residues
to effectively acetylate its substrates in vivo [34]. A search for
additional substrates has proven unsuccessful, and this is also the
case for the identification of putative auxiliary subunits which
potentially remain to be identified. Song et al. failed to detect any
phenotypes in a ynaa40-deletion strain [20]. However, Polevoda et
al. [34] later found that deletion of ynaa40 induced some minor
growth defects when this deletion strain was grown on media
containing an inhibitor of transcription (3-amino-1,2,4-triazole),
anti-mitotic microtubule-destabilizing drugs (benomyl and thia-
bendazole) or a nonspecific membrane inhibitor (dinitrobenzene).
A double mutant encoding histone H4 with K5R, K8R and K12R
replacements, as to create an Ne-unacetylatable mutant, in
addition to a disrupted ynaa40 gene, displayed an even greater
growth defect on media containing some of the aforementioned
compounds than either of the mutant strains alone, indicating that
the lack of Nt-acetylation of histone H4 acts synergistically with
the lack of lysine acetylation in the H4 tail, making Nt-acetylation
of histone H4 part of a charge patch, thereby explaining the
observed phenotypes based on a sub-optimal function of the
histone tail [34].
The objective in the present study was to identify and
investigate the human Naa40p/NatD. By the use of different
methods, we found that the substrate specificity of hNaa40p is
highly conserved from yeast, and recombinant hNaa40p was
indeed capable of acetylating synthetic H4 and H2A peptides in
vitro. Furthermore, heterologous hNaa40p also Nt-acetylated yeast
H4 in vivo. Endogenous hNaa40p was additionally found to be
associated with ribosomes in agreement with a co-translational
activity, but interestingly a fraction of hNaa40p was also found to
localize to the nucleus.
With the recent characterization of several human NATs and
the current identification of the human NatD, it is likely that all
human NATs acting co-translationally have been identified since
all classes of substrates found to be Nt- acetylated are covered.
Results and Discussion
A human homologue of the yeast N-alpha
acetyltransferase Naa40p (Nat4)
Sternglanz and coworkers previously identified yeast Naa40p
(Nat4) to be an Na-terminal acetyltransferase, responsible for
acetylating the N-termini of histones H2A and H4 [20]. In
addition, they predicted yNaa40p to have homologues in higher
eukaryotes, including humans. Later this putative human
homologue (accession number NP_079047) was denoted
hNaa40p, the catalytic subunit of the NatD type activity in
accordance with the revised NAT nomenclature [19]. An
alignment of the predicted Naa40 protein from different species
is shown in Figure 1A. Of importance is the conservation of the
acetyl-coenzyme A (Ac-CoA) binding motif, RxxGxG/A (where x
can be any amino acid), from yeast to humans. This motif is found
in all members of the Gcn5-related N-acetyltransferase (GNAT)
superfamily and is probably required for Ac-CoA binding to the
enzyme and hence its catalytic activity [36-38]. The conservation
of this binding motif, in addition to an overall sequence similarity
(23% amino acid sequence identity between yNaa40p and
hNaa40p), is also seen in the alignment of the putative human
Naa40p and the catalytical subunits of all characterized human
NATs (Figure 1B), which also revealed that some stretches of
amino acids are unique for Naa40p. These stretches are marked
with red lines above the alignment. The conservation of the Ac-
CoA binding motif is strongly indicative of an N-terminal
acetyltransferase activity, and the alignment point to hNaa40p as
being the yNaa40p orthologue.
hNaa40p is a NAT selectively acetylating Ser-Gly or
Gly-Gly starting peptides
Although the amino acid sequence of hNaa40p clearly supports
its candidacy as a novel human NAT of the NatD type, there is to
our knowledge no experimental evidence yet in support of this. In
order to assess whether hNaa40p is truly a NAT, the predicted
hNAA40 gene was cloned into a prokaryotic expression vector for
recombinant MBP-hNaa40p fusion protein expression. A recently
developed in vitro proteome-derived peptide library assay [30] was
performed for an largely unbiased characterization of the potential
enzymatic activity and substrate specificity of hNaa40p. As such,
177 unique substrate peptides were identified as being N-
terminally acetylated by hNaa40p, providing evidence that
hNaa40p is a genuine NAT. The resulting substrate specificity
profile of hNaa40p, displayed in Figure 2, illustrates that hNaa40p
preferentially acetylates Ser-Gly-Gly-Gly-Lys- starting peptides.
The similarity between the sequence presented in the specificity
profile and the N-terminal sequences of the human histones H2A
and H4 being Ser-Gly-Arg-Gly-Lys- is striking, only deviating at
position 3 with a Gly replaced by an Arg. It should be noted that
since the assay is based on an Ne-modified proteome-derived
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peptide library generated by the use of trypsin, internal Arginines
will be generally missed and consequently will be absent among
preferred N-terminal residues. The 177 substrate peptides
acetylated by hNaa40p in this screen range from 7-19 amino acid
residues in length, a result in contrast with the finding of Polevoda
et al. postulating that acetylation by yNaa40p required at least 30-
50 amino acid residues at the N-terminus of histone H2A and H4
[34]. The apparent difference in requirement for more residues in
the yeast experiments might implicate differences between species,
or solely reflect different requirements between an in vitro setting
with purified enzyme and peptides, and the in vivo setting in yeast
where a ribosome-bound yNaa40p targets the emerging nascent
polypeptide. For the in vitro assay described here, seven amino
acids are clearly enough to ensure specificity and acetylation by
hNaa40p. It should be noted that the N-termini in the peptide
library assay do not represent true N-termini since they are
generated by proteolytic cleavage. However, the significant match
between the hNaa40p substrates from the specificity profile and
the N-termini of histones H2A and H4 strongly suggests a
conserved function from yeast to humans with respect to Nt-
acetylation of histones H2A and H4.
hNaa40p N-terminally acetylates histones H2A and H4 in
vitro
In order to obtain further insight into the substrate specificity of
hNaa40p, the quantitative aspect of substrate Nt-acetylation, and
particularly the role of hNaa40p in histone acetylation thus
evaluating its candidacy as a true orthologue of yeast Naa40p/
NatD, an in vitro Nt- acetylation assay with purified recombinant
hNaa40p was conducted. hNaa40p was challenged by synthetic
peptides representing the N-termini of selected proteins, and
interestingly, hNaa40p strongly preferred histones H2A and H4
(Figure 3). A histone H4 peptide with a synthetically pre-acetylated
N-terminus was no longer acetylated efficiently by hNaa40p,
consistent with hNaa40p acetylating the a-amino group of H4 and
not significantly any of the lysine residues known to be Ne-
acetylated by lysine acetyltransferases (KATs) [39]. Furthermore,
only minor acetylation activity towards the HMG-1 (SESS),
hnRNPF (MLGP), or histone H3 (ARTQ) peptides was observed.
These three peptides are representatives of a classical NatA
substrate [1], a NatE substrate [28], and a non-acetylated N-
terminus [20], respectively. The lack of acetylation of the SESS
peptide could be explained by the fact that a Glu residue in
position P29 is generally inhibitory for hNaa40p acetylation
according to the specificity profile as deduced from the peptide
library assays (Figure 2).
To determine whether hNaa40p expressed in human cells
possesses specific acetyltransferase activity, as shown when using
recombinant hNaa40p purified from E. coli, hNaa40p-V5 was
expressed in HEK293 cells and immunoprecipitated. Immuno-
precipitated hNaa40p-V5 was used in an in vitro acetylation assay
with synthetic peptides as described in Material and Methods.
Histone H4 was significantly more acetylated as compared to the
N-terminally blocked peptide (Figure 4). Taken together, the
results from the in vitro experiments strongly suggest that hNaa40p
is a NAT conserved from yeast which specifically Nt-acetylates
histones H2A and H4 and that such specific acetylation may also
take place in cultured cells.
Ectopically expressed hNaa40p in yeast acetylates yeast
histone H4 but not H2A in vivo
In order to assess whether hNaa40p represents a true
orthologue of yNaa40p in vivo, we generated a yeast naa40-D
strain expressing hNaa40p (Figure 5). When comparing Nt-
acetylation of histones in control yeast (yeast Ctrl 1 or 2) to yeast
lacking NAA40 (ynaa40-D) and to the yeast strain lacking NAA40
but expressing hNaa40p (y[hNAA40]), hNaa40p expression
restored the diminished histone H4 acetylation (Figure 6). In fact,
the expression of hNaa40p increased the total level of H4-
acetylation (i.e. the combined Nt-acetylation and lysine acetylation
observed). This could indicate that Nt-acetylation stimulates lysine
acetylation in vivo, that hNaa40p is also capable of catalyzing lysine
acetylation of histone H4, or perhaps that the degree of Nt-
acetylation is higher in yeast expressing hNaa40p as compared to
yNaa40p. Lysine acetylation is normally catalyzed by the lysine
acetyltransferases (KATs), while Nt-acetylation is catalyzed by
NATs. However, a dual NAT/KAT-role for the NAT-enzymes
Figure 2. Sequence logos of the hNaa40p-specific substrate
peptide sequences enriched from a Na-free-peptide library. An
IceLogo of the 177 unique substrate peptides of recombinant hNaa40p
is shown (255 substrate peptides in total). Numbering is such that Nt-
acetylation occurs at position 0. Statistically significant residues with a
p-value threshold of 0.05 or less are plotted. The amino acids heights
are indicative for their degree of conservation at the indicated position.
The frequency of the amino acid occurrence at each position in
sequence set was compared with the human Swiss-Prot 56.0 database.
Residues with statistically significant 0% frequency of occurrence as
compared to Swiss-Prot are shown in pink. The N-terminal sequences of
human and yeast histone H2A and H4 are indicated.
doi:10.1371/journal.pone.0024713.g002
Figure 1. Amino acid alignments. (A) Amino acid sequence alignment of Naa40p from Drosophila melanogaster (Dm), Danio rerio (Dr), Mus
musculus (Mm), Homo sapiens (Hs), and Saccharomyces cerevisiae (Sc). (B) Amino acid sequence alignment of hNaa40p and the catalytical subunit of
NatA, NatB, NatC (residues 200–362), NatE and NatF. The conserved acetyl coenzyme A (Ac-CoA) binding motif RxxGxG/A, where x designates any
amino acid, is indicated in both alignments. The red lines above the alignment represent examples of stretches of amino acid residues unique to
Naa40p. Purple background indicates acidic residues, red indicates basic residues, orange indicates glycine, yellow indicates proline, blue indicates
hydrophobic residues, green indicates polar residues, and turquoise indicates histidine and tyrosine residues. The alignments were created using
Jalview multiple alignment editor [47,48].
doi:10.1371/journal.pone.0024713.g001
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Figure 3. Recombinant MBP-hNaa40p acetylates H2A and H4 N-termini in vitro. MBP-hNaa40p was incubated with [1-14C]-Ac-CoA and
selected peptides of 24–28 amino acids, representative of different protein N-termini. The first four N-terminal residues are shown for each substrate.
The Nt-Ac-H4 substrate is a histone H4 peptide where the N-terminus is blocked by an acetyl group. Incorporated acetyl groups were measured as
DPM. Error bars indicate standard deviation for at least three independent acetylation reactions.
doi:10.1371/journal.pone.0024713.g003
Figure 4. Immunoprecipitated hNaa40p-V5 acetylates histone H4 in vitro. (A) Immunoprecipitated hNaa40p-V5 acetylates histone H4 but
not the N-terminally blocked histone H4 peptide (Nt-Ac-H4). Error bars indicate standard deviation for three independent acetylation reactions.
Statistically significant results are indicated with * (p-value of 0.05 or less). The p-value (p = 0.0104) was calculated using Student’s t test. (B) Following
the acetylation assay, the agarose beads were subjected to SDS-PAGE and Western blotting using a specific antibody to the V5-tag.
doi:10.1371/journal.pone.0024713.g004
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has been suggested for hNaa50p [28,40] as well as for hNaa10p
[41,42]. The in vitro assays described above (Figures 3 and 4)
indicate that hNaa40p mostly acts as a NAT towards histone H4,
but a minor KAT activity might occur. Further detailed
experiments are required to conclude on this point. As expected,
no alterations in histone acetylation were observed for H2B and
H3 for any of the yeast strains used (data not shown). Surprisingly,
histone H2A, which was less acetylated in the yeast naa40-D strain
as compared to the controls, was not acetylated by hNaa40p
(Figure 6). This probably reflects the fact that the first five N-
terminal amino acid residues of histone H2A are altered from
yeast (Ser-Gly-Gly-Lys-Gly-) to humans (Ser-Gly-Arg-Gly-Lys-)
to become identical to the Nt-sequences of yeast and human
histone H4 (Ser-Gly-Arg-Gly-Lys-). From the in vitro specificity
profile (Figure 2), it is clear that Lys4 and Gly5 are not optimal for
hNaa40p activity. Naa40p might have evolved to become even
more specific in humans, acetylating the N-termini of the very
similar human H2A and H4, while the yeast homologue is able to
Nt-acetylate the more divergent N-termini of yeast H2A and H4.
Despite the lack of yeast histone H2A acetylation, the in vitro and in
vivo data combined, strongly suggest that hNaa40p is the true
orthologue of yNaa40p.
Subcellular localization of hNaa40p
Subcellular fractionation was performed to elucidate on the
localization pattern of hNaa40p. As shown in Figure 7 endogenous
hNaa40p localizes to both the cytoplasm and the nuclei of A431
cells. The same localization was also observed in HEK293 cells
(data not shown).
In addition, subcellular localization of exogenously expressed
hNaa40p-V5 was determined using immunofluorescence micros-
copy (Figure 8). In both cell lines investigated, HeLa and A431,
hNaa40p-V5 was found to have a distributed cytoplasmic
localization with some degree of nuclear localization. Surprisingly,
two main populations of localization patterns were observed, one
where hNaa40p-V5 was found mainly in the cytoplasm and to a
lesser degree in the nucleus (Figure 8, panel 1 (white arrow), and
2), and another where hNaa40p-V5 was found enriched in the
nucleus (Figure 8, panel 1 (red arrow), and 3). The latter could
possibly be due to an artificial nuclear accumulation of the
overexpressed protein. However, only low to medium intensity
cells were taken into account. In addition, cells with a low amount
of hNaa40p-V5 in the nucleus compared to the cytoplasm, were
also observed among highly overexpressing cells (figure S1).
Furthermore, there also existed a smaller population of cells in
which the fluorescence intensity level was equal in the two
compartments (data not shown), potentially representing an
intermediate or transition stage.
hNaa40p associates with ribosomes
NATs are involved in co-translational acetylation of nascent
polypeptides, and are therefore physically associated with
ribosomes. The yeast Naa40p was also demonstrated to associate
with ribosomes [34]. In order to investigate whether hNaa40p
shares this feature, ribosomes from HEK293 cells were isolated
and the binding of endogenous hNaa40p was analyzed by Western
blotting. Indeed, a small but reproducible fraction of hNaa40p was
detected in the polysomal pellet while the majority of hNaa40p
was present in the supernatant post ultracentrifugation (Figure 9).
As demonstrated here for the catalytic subunit of the NatA
complex, hNaa10p, this pattern is similar to what was observed
previously for all the other human NAT subunits [10,30,33,43].
yNaa10p has previously been shown to associate with ribosomes
through an interaction with the auxiliary subunit yNaa15p [23].
No such auxiliary subunit has been identified for Naa40p neither
in yeast nor in humans, suggesting that hNaa40p itself might
interact with the ribosome directly. However, the lack of identified
additional NatD subunit(s) does not exclude their presence. The
large fraction of hNaa40p not in complex with ribosomes indicates
that most of hNaa40p is in a free form in the cytoplasm or in the
nucleus based on the fractionation and immunofluorescence
experiments presented above.
Concluding remarks
In conclusion, we have here identified the human Naa40p (NatD)
acting as a co-translational NAT towards the N-termini of the
histones H2A and H4. Overall, the set of functionally characterized
human NATs now comprises NatA-NatF which are likely to be
responsible for all co-translational Nt-acetylation events in human
cells. A potential role for hNaa40p in the nucleus as well as a
potential function as a KAT awaits further investigation.
Materials and Methods
Construction of plasmids
The plasmid (phNAA40-V5) encoding V5-tagged hNaa40p was
constructed from cDNA made from total RNA isolated from
human HEK293 cells. SuperscriptTMII Reverse Transcriptase
(Invitrogen) was used to make cDNA. PCR products were inserted
into the TOPO TA vector pcDNA 3.1/V5-His TOPOH
(Invitrogen) according to the instruction manual. Prokaryotic
expression vector for hNAA40 was made by subcloning the
amplified hNAA40 gene from phNAA40-V5 to the pETM41
expression vector using XmaI and EcoRI restriction sites. pETM41
was generously provided by G. Stier, EMBL, Heidelberg.
E. coli hNaa40p expression and purification
E. coli BL21 StarTM (DE3) (Invitrogen) was transformed by heat
shock with the pETM41-hNAA40 plasmid encoding a MBP-
Figure 5. Generation of yeast strains. Three yeast strains were
made by transformation; A normal yeast strain expressing normal levels
of yNaa40p (Ctrl). A strain where the yNAA40 gene was disrupted by
insertion of a kanMX cassette (ynaa40-D), and a ynaa40 deletion strain
ectopically expressing hNAA40 (y[hNAA40]). (A) Disruption of NAA40 was
verified by isolation of genomic DNA, and PCR using NAA40-specific
primers. (B) Western Blotting using a specific anti-hNaa40p antibody
confirmed the expression of hNaa40p in the y[hNAA40] strain.
doi:10.1371/journal.pone.0024713.g005
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hNaa40p fusion protein, and grown overnight on LB agar
containing kanamycin. A well separated colony was picked and
inoculated at 37uC in 200 ml LB medium supplemented with
kanamycin to an OD600 of 0.6. Protein expression was induced by
IPTG (1 mM) at 20uC for 18 hours. The culture was harvested by
centrifugation at 3000 x g for 20 minutes. The cells were lysed by
sonication in lysis buffer (50 mM Tris-HCl (pH 8.3), 300 mM
NaCl, 1 mM DTT, 1 tablet EDTA-free protease Inhibitor cocktail
per 50 ml (Roche)) and cleared by centrifugation at 10000 x g for
20 minutes. Cleared lysate was applied on a metal affinity FPLC
column (HisTrap HP, GE Healthcare, Uppsala, Sweden), and
MBP-hNaa40p was eluted with 300 mM imidazole in 50 mM Tris
(pH 8.3), 300 mM NaCl, 1 mM DTT. MBP-hNaa40p was further
purified on a size exclusion chromatography column (SuperdexTM
75, GE Healthcare).
In vitro proteome-derived peptide library Nt-acetylation
assay
Proteome-derived Na-free peptide libraries were generated from
human K-562 cells as described previously [30]. 100 nmol of the
desalted Na-free peptide pool was reconstituted in acetylation
buffer (50 mM Tris-HCl (pH 8.3), 1 mM DTT, 800 mM EDTA,
10% glycerol) together with equimolar amounts of a stable isotope
encoded variant of acetyl-CoA, 13C2-acetyl CoA, (99%
13C2-acetyl
CoA, ISOTEC-Sigma (lithium salt)) and 500 pmol of enzyme (i.e.
recombinant MBP-hNaa40p) was added to a final reaction volume
of 500 ml. The reaction was allowed to proceed for 2 h at 37uC
and stopped by addition of acetic acid to a 5% final concentration.
NAT oligopeptide-substrate recovery and LC-MS/MS analyses
was performed as decribed previously [30].
LC-MS/MS analysis
LC-MS/MS analysis was performed as described previously
[30]. The generated MS/MS peak lists were then searched with
Mascot using the Mascot Daemon interface (version 2.2.0, Matrix
Science). Searches were performed in the Swiss-Prot database with
taxonomy set to human (Homo sapiens) (UniProtKB/Swiss-Prot
database). Trideutero(d3)-acetylation at lysines, carbamidomethy-
lation of cysteine and methionine oxidation to methionine-
sulfoxide were set as fixed modifications. Variable modifications
included 13C2-acetylation, d3-acetylation, acetylation and pyroglu-
tamate formation of N-terminal glutamine. Endoproteinase Arg-
C/P (Arg-C specificity with arginine-proline cleavage allowed) was
set as enzyme allowing no missed cleavages. The mass tolerance
on the precursor ion was set to 10 ppm and on fragment ions to
0.5 Da. Peptide identifications were considered significant when
their Mascot ion score was above the identity threshold set at a
99% confidence interval and when they were top-ranked.
In vitro acetylation assay using synthetic oligopeptides as
substrates
For the in vitro acetylation assay using custom-made synthetic
peptides, purified MBP-hNaa40p (400 nM) was mixed with
selected oligopeptide substrates (200 mM) and 200 mM of [1-14C]
acetyl-CoA in a total volume of 170 ml acetylation buffer (50 mM
Tris-HCl (pH 8.3), 800 mM EDTA, 10% glycerol, 1 mM DTT)
and incubated for 1 hour at 37uC. Following incubation, 150 ml
SP Sepharose beads (50% slurry with 0.5 M acetic acid) were
added to the mix and incubated at room temperature for 5
minutes. After centrifugation 6000 x g for 2 min, the beads were
washed three times with 0.5 M acetic acid. Following the last
wash, the supernatant was removed and the beads washed with
300 ml ice cold methanol, after centrifugation the supernatant was
removed and the beads were transferred to 5 ml counting fluid
and radioactivity was measured as disintegrations per minute
(DPM) using a scintillation counter.
For the immunoprecipitation experiments, HEK293 cells were
transfected with a plasmid encoding hNaa40p-V5 using FugeneH 6
Transfection reagent. Cells were harvested 48 hours post-trans-
fection and resuspended in lysis buffer (50 mM Tris-HCl (pH 7.5),
150 mM NaCl, 5 mM EDTA, 0.5% NP-40, Pefabloc). After lysis
on ice for five minutes, the lysate was cleared by centrifugation
3000 x g for 5 minutes. hNaa40p-V5 was immunoprecipitated
from the lysate using specific antibodies against the V5-tag
(Invitrogen) and Protein A/G Agarose beads (Santa Cruz).
Immunoprecipitation using antibodies against the Xpress-tag
(Invitrogen) was used as a negative control. Following washing (3
times) with lysis buffer and acetylation buffer the immunoprecip-
itates were used in an in vitro acetylation assay as described above.
Yeast strain generation and cultivation for histone
isolation
Yeast was grown and manipulated according to standard
procedures [44]. Expression vector for hNAA40 was made by
subcloning the amplified hNAA40 gene from phNAA40-V5 to
pBEVY-U bidirectional expression vector [45] using the BsmBI
restriction site.
The S. cerevisiae MAT alpha strain Y10000 was transformed with
pBEVY-U and acted as control strains (yeast Ctrl). Strain Y16202
Figure 7. Endogenous hNaa40p localizes to the cytosol and
nucleus. A431 cells were harvested and fractionated. Total cell lysate
(T), cytosolic fraction (C), and nuclear fraction (N) were analyzed by SDS-
PAGE and western blotting. Beta-tubulin was used as a cytosolic marker,
while histone H4 was used as a nuclear marker. hNaa40p was detected
in all fractions using an anti-hNaa40p antibody. Results shown are
representative of three independent experiments.
doi:10.1371/journal.pone.0024713.g007
Figure 6. Ectopically expressed hNaa40p in yeast acetylates histone H4 but not H2A in vivo. (A) The mature N-terminus of yeast histone
H2A (2SGGKGGKAGSAAKASQSR19) (left panels) and H4 (2SGRGKGGKGLGKGGAKR18) (right panels) was identified as being partially in vivo N-acetylated.
Various N-acetylated forms of these histone N-termini were detected in all samples analyzed. A decrease of 5 Da, corresponds with the gain of an
extra in vivo N-acetyl group (i.e. all free amines were in vitro N-acetylated using 13C2D3-NHS acetate; i.e. adding a 5 Da heavier acetyl group to free
amines). Colored squares indicate the number of in vivo (orange) and in vitro (gray) acetyl group present per detected isotopic envelope. Clearly
deletion of yNAA40 reduces the overall degree of N-acetylation (middle panels) for both histone N-termini while the ectopic expression of hNaa40p
restores and even augments the degree of N-aectylation of the H2A N-terminus, while not having any observable effect on the overall N-acetylation
status of the H4 N-terminus (B) The percentage of all isobaric N-terminal variants as shown in panel A were calculated and their contribution to the
overall percentage of the respective histone N-terminus plotted.
doi:10.1371/journal.pone.0024713.g006
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(naa40-D, Euroscarf) was transformed with pBEVY-U or pBEVY-
U-hNAA40 to generate the strains ynaa40-D and y[hNAA40],
respectively. The three strains generated were selected on plates
lacking uracil. Disruption of NAA40 was verified by isolation of
genomic DNA, and PCR using the primers yNAA40-86F: 59-
CCACATATGTATGCGCGGTGC-39 and yNAA40 941R: 59-
GGAGTCAAGGATTCGAGTCGC-39. Expression of hNaa40p
was verified by SDS-PAGE and Western blotting analysis of yeast
lysates using anti-hNaa40p (Biosite).
For histone isolation, the strains were cultivated in 10 ml
synthetic medium lacking uracil (Sigma) to an OD600 nm of ,3.
Cells were collected by centrifugation for 5 min at 1500 x g and
resuspended in 500 ml lysis buffer (0.2% TRITON-X-100, 10 mM
HEPES (pH 7.6) 1.5 mM MgCl2, 10 mM KCl, 1 mM Pefabloc, 1
mM Na3VO4 and 5 mM TSA). Glass beads were added before
several rounds of vortex/ice. After lysis, the glass beads were
removed and the supernatant was centrifuged for 5 minutes at
3000 x g. Pellets were washed in lysis buffer followed by
centrifugation for 5 min at 300 x g. The pellets were incubated
in 0.4 M HCl for 1 hour and centrifuged for 15 min at 13000 x g.
6 volumes of ice-cold aceton were added to the supernatant and
acid-extracted proteins precipitated overnight at 220uC. After
centrifugation for 15 min at 13000 x g, and 3 rounds of washing
with ice-cold aceton the pellets were dried for 5 min in a vacuum
concentrator.
SDS-PAGE of histone samples and determination of the
N-acetylation status of yeast histone N-termini using
in-gel stable-isotope labeling (ISIL) followed by in-gel
digestion
All dried histone pellets were dissolved in 50 ml sample buffer (8
M urea, 5% b-mercaptoethanol and 10 mM Tris-HCl (pH 7.0)).
20 ml of each sample was added SDS-sample buffer (Biorad XT
sample buffer) and the samples were analyzed on a 4%-16%
gradient XT precast Criterion gel using XT-MOPS buffer
(Biorad).
In-gel-stable isotope labelling was performed as described
previously [43] with the following modifications; primary amines
were (13C2d3)-acetylated by the addition of 1 mg N-hydroxysucci-
nimide (13C2d3)-acetate and trypsin digestion proceeded for 309 at
37uC, representative of a sub-optimal incubation time, to increase
the occurrence of missed cleavages (i.e. the yeast histone H4 N-
Figure 8. Subcellular localization of hNaa40p-V5. A431 cells or HeLa cells were transfected with plasmid encoding hNaa40p-V5. The V5-tagged
hNaa40 protein was visualized using mouse IgG2a Anti-V5 and Alexa-594 conjugated anti-mouse IgG2a monoclonal antibody. Hoechst (33342)
staining was used to visualize the cell nuclei. hNaa40p-V5 displayed a distributed cytoplasmic localization with some degree of nuclear localization.
Note that the degree of nuclear localization varied between individual cells in the same sample, some expressing hNaa40p mainly in the cytosol and
to a lesser degree in the nucleus (Panel 1 (white arrow, and 2); and others showing hNaa40p enriched in the nucleus (Panel 1 (red arrow), and 3). Scale
bars are 5 mm.
doi:10.1371/journal.pone.0024713.g008
Figure 9. A fraction of hNaa40p co-sediments with polysomes.
Polysomal pellets from HEK-293 cells were resuspended in buffer
containing increasing concentrations of KCl. Cell lysate (L), supernatant
post first ultracentrifugation (S) and polysomal pellets after KCl
treatment were analyzed by SDS-PAGE and Western blotting. The
membrane was incubated with anti-hNaa40p, anti-hNaa10p, anti-L26
(ribosomal protein), and anti-CytC antibodies. Results shown are
representative of three independent experiments.
doi:10.1371/journal.pone.0024713.g009
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terminus harbours an Arg-residue at the third position (i.e. the N-
terminus w/o the iMet)) thereby allowing for the identification of
the yeast H4 histone N-terminus (next to the H2A N-terminus).
The resulting peptide mixtures were acidified (0.1% formic acid)
and analyzed by LC-MS/MS analysis as described previously
[43]. The generated MS/MS peak lists were then searched with
Mascot using the Mascot Daemon interface (version 2.2.0, Matrix
Science). Searches were performed in the Swiss-Prot database with
taxonomy set to human (Homo sapiens) (UniProtKB/Swiss-Prot
database). 13C2d3- or normal acetylation at lysines,
13C2d3- or
normal acetylation of the N-terminus, pyro-glutamate formation
of N-terminal glutamine and methionine oxidation to methionine-
sulfoxide were set as variable modifications. Endoproteinase Arg-
C/P (Arg-C specificity with arginine-proline cleavage allowed) was
set as enzyme allowing 2 missed cleavages. The mass tolerance on
the precursor ion was set to 10 ppm and on fragment ions to
0.5 Da. Peptide identifications were considered significant when
their Mascot ion score was above the identity threshold set at a
99% confidence interval and when they were top-ranked.
The extent of histone N-acetylation was calculated from the
peptide ion signals observed in the MS spectra as described in [3].
Cell culture
HEK293 cells (human embryonic kidney 293 cells; A.T.C.C. no.
CRL-1573), HeLa cells (epithelial cervix adenocarcinoma; A.T.C.C.
no. CCL-2), and A431 cells (human epidermoid carcinoma cells
A.T.C.C. no. CRL-1555) were cultured in 5% CO2 at 37uC in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% heat inactivated fetal bovine serum (FBS), and 3% L-glutamine.
Immunofluorescence
For fluorescent microscopic analysis, cells were transfected with
plasmid encoding hNaa40p-V5. Transfection was carried out using
FugeneH 6 Transfection reagent (Roche) and 0.5 mg plasmid per ml
medium. 24 hours post transfection, cells were incubated for 10 min
with Hoechst 33342 (Invitrogen) (0.4 ml per ml medium). Cells were
then washed in PBS and fixed for 20 min in 4% paraformaldehyde
in PBS. Fixed cells were washed three times in PBS, permeabilized
using 0.2% Triton X-100 for 10 min and then washed once in PBS
before incubation in blocking buffer (10% BSA) for 1 hour. Primary
antibody, Mouse IgG2a anti-V5 (Invitrogen), diluted 1:200 in 2%
BSA was incubated for 1 h. Cells were washed one time in 0.1%
Triton X-100 for 5 min, followed by two washes in PBS. The
fluorochrome-conjugated secondary antibody, Alexa FluorH 594
goat anti-mouse IgG2a (Molecular Probes, Eugene, Oregon, USA),
diluted 1:100 in 2% BSA was incubated for 40 min. Cells were
again washed once in 0.1%Triton X-100 for 5 min followed by two
PBS washes. Finally, coverslips were dipped in ddH2O before
mounting on glass slides using SlowFade Gold antifade reagent
(Invitrogen) after which coverslips were sealed. Imaging was
performed using a Leica DMRXA microscope equipped with a
26magnification lens, a Leica DC500 camera, and a Leica HCX
PLAPO 1006oil immersion objective. Hoechst stain was visualized
using a 340–380 nm bandpass filter with longpass suppression filter
(425 nm); Alexa-594 was visualized using a 560/40 nm bandpass
filter with bandpass suppression filter (645/75 nm). Untransfected
cells and secondary antibody staining only were considered as a
control for unspecific binding of the antibodies.
Subcellular fractionation
Subcellular fractionation was used to separate nuclear from
cytosolic proteins. Based on the protocol by Suzuki et al. [46], cells
were washed in PBS and harvested by ‘‘pop spin’’ for 10 seconds
(3000 x g). The resulting cell pellet was resuspended in 900 ml of
ice-cold lysis buffer (0.1% NP40 in PBS) and a sample was taken as
total lysate fraction. Following a second pop-spin for 10 seconds, a
sample from the supernatant was removed representative of the
cytosolic fraction. The nuclear pellet was washed by resuspension
in 1 ml lysis buffer followed by centrifugation for 10 seconds. The
supernatant was discarded and the pellet was resuspended in
sample buffer and designated as the nuclear fraction. The nuclear
fraction and the total lysate fraction were sonicated two times for
10 seconds. The subcellular fractions were analysed by SDS-
PAGE and Western blotting.
Ribosome isolation
Approximately 26107 HEK293 cells were used per experiment.
Prior to harvesting, cells were treated with 10 mg/ml cyclohexi-
mide (CHX) for 5 minutes at 37uC. Cells were harvested, lysed
with KCl-containing ribosome lysis buffer (1.1% (w/v) KCl,
0.15% (w/v) triethanolamine, 0.1% (w/v) magnesium acetate,
8.6% (w/v) sucrose, 0.05% (w/v) sodium deoxycholate, 0.5% (v/v)
Triton-X100, 0.25% (v/v) Pefabloc), and incubated on ice for 15
minutes. After removing the nuclear and membrane containing
fraction by centrifugation at 4006 g for 10 min, 700 ml cell lysate
was ultracentrifuged at 436,0006 g for 25 minutes on a 0.4 ml
cushion of 25% sucrose in KCl ribosome lysis buffer using a MLA-
130 rotor (Beckman, Geneva, Switzerland). Pellets were re-
suspended in ribosome lysis buffer with the indicated KCl
concentrations, followed by ultracentrifugation as described above.
Pellets were re-suspended in KCl ribosome lysis buffer, and
prepared for analysis by SDS-PAGE and Western blotting.
Supporting Information
Figure S1 Subcellular localization of hNaa40p-V5 in
highly overexpressing cells. A431 and HeLa cells were
prepared as described in Figure 8. The same expression pattern as
shown in Figure 8 (panel 1 (white arrows), and 2) was also observed
in highly overexpressing cells. Scale bars are 5 mm.
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